RHYTHM PHARMACEUTICALS, INC. Net Income (Loss) Attributable to Parent in USD from 2017 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Rhythm Pharmaceuticals, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2017 to Q3 2025.
  • Rhythm Pharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2025 was -$52.9M, a 21.2% decline year-over-year.
  • Rhythm Pharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2025 was -$192M, a 25.7% increase year-over-year.
  • Rhythm Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2024 was -$261M, a 41.1% decline from 2023.
  • Rhythm Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$185M, a 1.97% decline from 2022.
  • Rhythm Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$181M, a 160% decline from 2021.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)

RHYTHM PHARMACEUTICALS, INC. Quarterly Net Income (Loss) Attributable to Parent (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 -$192M -$52.9M -$9.26M -21.2% Jul 1, 2025 Sep 30, 2025 10-Q 2025-11-04
Q2 2025 -$183M -$46.6M -$14.4M -44.5% Apr 1, 2025 Jun 30, 2025 10-Q 2025-11-04
Q1 2025 -$169M -$49.5M +$91.9M +65% Jan 1, 2025 Mar 31, 2025 10-Q 2025-11-04
Q4 2024 -$261M -$43.3M -$1.7M -4.07% Oct 1, 2024 Dec 31, 2024 10-K 2025-02-28
Q3 2024 -$259M -$43.6M +$522K +1.18% Jul 1, 2024 Sep 30, 2024 10-Q 2025-11-04
Q2 2024 -$259M -$32.3M +$14.4M +30.9% Apr 1, 2024 Jun 30, 2024 10-Q 2025-11-04
Q1 2024 -$274M -$141M -$89.2M -171% Jan 1, 2024 Mar 31, 2024 10-Q 2025-11-04
Q4 2023 -$185M -$41.6M +$860K +2.02% Oct 1, 2023 Dec 31, 2023 10-K 2025-02-28
Q3 2023 -$186M -$44.2M -$3.3M -8.08% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-06
Q2 2023 -$182M -$46.7M -$1.7M -3.78% Apr 1, 2023 Jun 30, 2023 10-Q 2024-11-06
Q1 2023 -$181M -$52.2M +$585K +1.11% Jan 1, 2023 Mar 31, 2023 10-Q 2024-11-06
Q4 2022 -$181M -$42.5M +$373K +0.87% Oct 1, 2022 Dec 31, 2022 10-K 2025-02-28
Q3 2022 -$181M -$40.9M -$5.75M -16.4% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 -$176M -$45M -$9.61M -27.2% Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-08
Q1 2022 -$166M -$52.8M -$96.5M -221% Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-08
Q4 2021 -$69.6M -$42.9M -$7.97M -22.8% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-29
Q3 2021 -$61.6M -$35.1M -$1.29M -3.81% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 -$60.4M -$35.4M -$4.27M -13.7% Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-08
Q1 2021 -$56.1M $43.8M +$77.9M Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-08
Q4 2020 -$134M -$34.9M -$1.94M -5.89% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-01
Q3 2020 -$132M -$33.8M +$2.19M +6.07% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-02
Q2 2020 -$134M -$31.1M +$11.7M +27.3% Apr 1, 2020 Jun 30, 2020 10-Q 2021-11-02
Q1 2020 -$146M -$34.2M -$5.19M -17.9% Jan 1, 2020 Mar 31, 2020 10-Q 2021-11-02
Q4 2019 -$141M -$33M -$7.45M -29.2% Oct 1, 2019 Dec 31, 2019 10-K 2020-03-02
Q3 2019 -$133M -$36M -$18.3M -104% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-02
Q2 2019 -$115M -$42.8M -$28.4M -197% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-03
Q1 2019 -$86.6M -$29M -$12.5M -76% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-04
Q4 2018 -$74.1M -$25.5M Oct 1, 2018 Dec 31, 2018 10-K 2020-03-02
Q3 2018 -$17.7M Jul 1, 2018 Sep 30, 2018 10-K 2020-03-02
Q2 2018 -$14.4M Apr 1, 2018 Jun 30, 2018 10-K 2020-03-02
Q1 2018 -$16.5M Jan 1, 2018 Mar 31, 2018 10-K 2020-03-02

RHYTHM PHARMACEUTICALS, INC. Annual Net Income (Loss) Attributable to Parent (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$261M -$75.9M -41.1% Jan 1, 2024 Dec 31, 2024 10-K 2025-02-28
2023 -$185M -$3.56M -1.97% Jan 1, 2023 Dec 31, 2023 10-K 2025-02-28
2022 -$181M -$112M -160% Jan 1, 2022 Dec 31, 2022 10-K 2025-02-28
2021 -$69.6M +$64.4M +48% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-29
2020 -$134M +$6.73M +4.78% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-01
2019 -$141M -$66.7M -90% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-01
2018 -$74.1M -$40.4M -120% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-02
2017 -$33.7M Jan 1, 2017 Dec 31, 2017 10-K 2020-03-02
* An asterisk sign (*) next to the value indicates that the value is likely invalid.